5-(4-Methylpiperazin-1-yl)-2-nitroaniline

Catalog No. :
ACLXVA389
CAS No. :
23491-48-7
Molecular Formula :
C11H16N4O2
Molecular Weight :
236.27

IUPAC Name:5-(4-methylpiperazin-1-yl)-2-nitroaniline

5-(4-Methylpiperazin-1-yl)-2-nitroaniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g95%$51.00Login to see priceIn stockInquiry
25g95%$127.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(4-Methylpiperazin-1-yl)-2-nitroaniline
IUPAC Name5-(4-methylpiperazin-1-yl)-2-nitroaniline
MDL No.MFCD00545964
Molecular FormulaC11H16N4O2
Molecular Weight236.27
SMILESNC1=CC(N2CCN(C)CC2)=CC=C1[N+]([O-])=O
InChI KeyMWLBMGPQZJDFKZ-UHFFFAOYSA-N
Synonym23491-48-7 | 5-(4-methylpiperazin-1-yl)-2-nitroaniline | 5-(4-Methylpiperazin-1-yl)-2-nitrophenylamine | 5-(4-methylpiperazino)-2-nitroaniline | 5-(4-Methyl-piperazin-1-yl)-2-nitro-phenylamine | CHEMBL1370863 | 5-(4-methylpiperazin-1-yl)-2-nitrobenzenamine | MFCD005459
CAS No.23491-48-7
PubChem CID2760034

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACLXVA389 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5 In Stock
  2. Plus
  3. ACUNRB895 route compound structure diagram
    ACUNRB8952369-11-1 In Stock
  4. Then
  5. ACLXVA389 route product structure diagram
    ACLXVA38923491-48-7 In Stock
Inquiry

2. ACLXVA389 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLXVA389 route product structure diagram
    ACLXVA38923491-48-7 In Stock
Inquiry

Comments (0)